- Credit Suisse 30th Annual Healthcare Conference on
Tuesday, November 9, 2021 at12:10 p.m. E.T. - Barclays Gene Editing & Gene Therapy Summit 2021 on
Monday, November 15, 2021 at3:00 p.m. E.T. Evercore ISI 4th AnnualHealthCONx Conference onTuesday, November 30, 2021 at1:25 p.m. E.T.
The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
Source:
Investor Contact:
iestepan@sarepta.com
Media Contact:
tsorrentino@sarepta.com
Source:
2021 GlobeNewswire, Inc., source